Molecular structure of Atorvastatin calcium salt trihydrate, CAS Number: 344423-98-9
Atorvastatin calcium salt trihydrate (CAS 344423-98-9)
Application:
Atorvastatin calcium salt trihydrate is a specific inhibitor of HMGCR
CAS Number:
344423-98-9
Purity:
≥98%
Molecular Weight:
1209.38
Molecular Formula:
(C33H34FN2O5)2•Ca•3H2O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Atorvastatin calcium salt trihydrate is primarily used in biochemical research involving lipid metabolism. This compound aids in the study of enzyme inhibition, particularly focusing on enzymes involved in cholesterol synthesis pathways. Researchers utilize Atorvastatin calcium salt trihydrate to explore the regulatory mechanisms of lipid levels within cells, which contributes to broader understanding in metabolic studies. Additionally, this chemical is instrumental in investigations of gene expression related to lipid metabolism, providing insights into the genetic factors that influence enzyme activity.
Atorvastatin calcium salt trihydrate (CAS 344423-98-9) References
- Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery. | Thompson, BJ., et al. 2014. J Cereb Blood Flow Metab. 34: 699-707. PMID: 24473481
- Effect of the interaction between atorvastatin and selective serotonin reuptake inhibitors on the blood redox equilibrium. | Herbet, M., et al. 2016. Exp Ther Med. 12: 3440-3444. PMID: 27882176
- CNOT2 Is Critically Involved in Atorvastatin Induced Apoptotic and Autophagic Cell Death in Non-Small Cell Lung Cancers. | Lee, J., et al. 2019. Cancers (Basel). 11: PMID: 31574980
- Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats. | Karbownik, A., et al. 2020. Pharmaceutics. 12: PMID: 32605304
- Anti-Proliferative Effect of Statins Is Mediated by DNMT1 Inhibition and p21 Expression in OSCC Cells. | Dongoran, RA., et al. 2020. Cancers (Basel). 12: PMID: 32731382
- Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer. | Luo, Y., et al. 2021. Transl Lung Cancer Res. 10: 128-142. PMID: 33569299
- Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9. | Li, H., et al. 2021. Exp Ther Med. 22: 1381. PMID: 34650629
- Statin-mediated disruption of Rho GTPase prenylation and activity inhibits respiratory syncytial virus infection. | Malhi, M., et al. 2021. Commun Biol. 4: 1239. PMID: 34716403
- Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice. | Du, L., et al. 2022. Front Cell Infect Microbiol. 12: 729940. PMID: 35573781
- StemPanTox: A fast and wide-target drug assessment system for tailor-made safety evaluations using personalized iPS cells. | Yamane, J., et al. 2022. iScience. 25: 104538. PMID: 35754715
- Effects of Statin Combinations on Zika Virus Infection in Vero Cells. | Españo, E. and Kim, JK. 2022. Pharmaceutics. 15: PMID: 36678679
- Mevalonate biosynthesis pathway regulates the development and survival of brown adipocytes. | Kwon, J., et al. 2023. iScience. 26: 106161. PMID: 36895651
- Investigating potential anti-proliferative activity of different statins against five cancer cell lines. | Sarbassova, G., et al. 2023. Saudi Pharm J. 31: 727-735. PMID: 37181137
Inhibitor of:
HMGCR.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Atorvastatin calcium salt trihydrate, 10 mg | sc-364723 | 10 mg | $143.00 | |||
Atorvastatin calcium salt trihydrate, 25 mg | sc-364723A | 25 mg | $398.00 | |||
Atorvastatin calcium salt trihydrate, 100 mg | sc-364723B | 100 mg | $648.00 |